Is heat shock protein 60 associated with type 2 diabetes mellitus?

Diabetes Research and Clinical Practice

Volumn 85, Issue 2, 2009, Pages 208-212

  Imatoh, T ^a   Sugie, T ^b   Miyazaki, M ^c   Tanihara, S ^a   Baba, M ^a   Momose, Y ^a   Uryu, Y ^a   Une, H ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c National Institute of Health Sciences   (Japan)

Author keywords

Epidemiological study; HSP60; Type 2 diabetes mellitus

Indexed keywords

HEAT SHOCK PROTEIN 60;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADIPONECTIN; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CHAPERONIN 60; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 67649834498     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.06.004     Document Type: Article

References (21)

1. Krakoff J., Funahashi T., Stehouwer C.D., Schalkwijk C.G., Tanaka S., Matsuzawa Y., et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26 (2003) 1745-1751
2. Helmersson J., Vessby B., Larsson A., and Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109 (2004) 1729-1734
3. Ellis R.J., and van der Vies S.M. Molecular chaperones. Annu Rev Biochem 60 (1991) 321-347
4. Becker J., and Craig E.A. Heat-shock proteins as molecular chaperones. Eur J Biochem 219 (1994) 11-23
5. Xu Q., Schett G., Seitz C.S., Hu Y., Gupta R.S., and Wick G. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 75 (1994) 1078-1085
6. Wick G., Knoflach M., and Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22 (2004) 361-403
7. Pockley A.G., Wu R., Lemne C., Kiessling R., De Faire U., and Frostegard J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 36 (2000) 303-307
8. Pockley A.G., De Faire U., Kiessling R., Lemne C., Thulin T., and Frostegard J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens 20 (2002) 1815-1820
9. Shamaei-Tousi A., Steptoe A., O'Donnell K., Palmen J., Stephens J.W., Hurel S.J., et al. Plasma heat shock protein 60 and cardiovascular disease risk: the role of psychosocial, genetic, and biological factors. Cell Stress Chaperones 12 (2007) 384-392
10. Shamaei-Tousi A., Stephens J.W., Bin R., Cooper J.A., Steptoe A., Coates A.R., et al. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J 27 (2006) 1565-1570
11. Xu Q., Schett G., Perschinka H., Mayr M., Egger G., Oberhollenzer F., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102 (2000) 14-20
12. Kurucz I., Morva A., Vaag A., Eriksson K.F., Huang X., Groop L., et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 51 (2002) 1102-1109
13. Lindquist S., and Craig E.A. The heat-shock proteins. Annu Rev Genet 22 (1988) 631-677
14. Child D.F., Williams C.P., Jones R.P., Hudson P.R., Jones M., and Smith C.J. Heat shock protein studies in type 1 and type 2 diabetes and human islet cell culture. Diabet Med 12 (1995) 595-599
15. Pockley A.G., Bulmer J., Hanks B.M., and Wright B.H. Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones 4 (1999) 29-35
16. Lewthwaite J., Owen N., Coates A., Henderson B., and Steptoe A. Circulating human heat shock protein 60 in the plasma of British civil servants: relationship to physiological and psychosocial stress. Circulation 106 (2002) 196-201
17. Chen H.S., Shan Y.X., Yang T.L., Lin H.D., Chen J.W., Lin S.J., et al. Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 54 (2005) 175-181
18. Snijder M.B., Heine R.J., Seidell J.C., Bouter L.M., Stehouwer C.D., Nijpels G., et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: The Hoorn Study. Diabetes Care 29 (2006) 2498-2503
19. Jalovaara K., Santaniemi M., Timonen M., Jokelainen J., Kesaniemi Y.A., Ukkola O., et al. Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. Metabolism 57 (2008) 1130-1134
20. Cohen-Sfady M., Nussbaum G., Pevsner-Fischer M., Mor F., Carmi P., Zanin-Zhorov A., et al. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol 175 (2005) 3594-3602
21. Febbraio M.A., Mesa J.L., Chung J., Steensberg A., Keller C., Nielsen H.B., et al. Glucose ingestion attenuate the exercise-induced increase in circulating heat shock protein 72 and heat shock protein 60 in humans. Cell Stress Chaperones 9 (2004) 390-396